234 related articles for article (PubMed ID: 11220247)
21. Molecular epidemiology,
Li W; Zhang ZW; Luo Y; Liang N; Pi XX; Fan YM
J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
[No Abstract] [Full Text] [Related]
22.
Saunte DML; Gaitanis G; Hay RJ
Front Cell Infect Microbiol; 2020; 10():112. PubMed ID: 32266163
[TBL] [Abstract][Full Text] [Related]
23. [Superficial mycoses in immunosuppressed patients].
Hernanz Hermosa JM; Lázaro Ochaita P
Rev Clin Esp; 1995 Oct; 195 Suppl 3():49-55. PubMed ID: 9441306
[No Abstract] [Full Text] [Related]
24. Malassezia infections: a medical conundrum.
Pedrosa AF; Lisboa C; Gonçalves Rodrigues A
J Am Acad Dermatol; 2014 Jul; 71(1):170-6. PubMed ID: 24569116
[TBL] [Abstract][Full Text] [Related]
25. Malassezia species in healthy skin and in dermatological conditions.
Prohic A; Jovovic Sadikovic T; Krupalija-Fazlic M; Kuskunovic-Vlahovljak S
Int J Dermatol; 2016 May; 55(5):494-504. PubMed ID: 26710919
[TBL] [Abstract][Full Text] [Related]
26. The Pityrosporon yeasts. Their role as pathogens.
Faergemann J; Maibach HI
Int J Dermatol; 1984 Sep; 23(7):463-5. PubMed ID: 6238011
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and skin tolerability of saliker in the treatment of dandruff.
Schwartz JR
Eur J Dermatol; 2002; 12(6):617. PubMed ID: 12506888
[No Abstract] [Full Text] [Related]
28. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options.
Faergemann J; Jones JC; Hettler O; Loria Y
Br J Dermatol; 1996 Jun; 134 Suppl 46():12-5: discussion 38. PubMed ID: 8763461
[TBL] [Abstract][Full Text] [Related]
29. [Not Available].
Buttafuoco A; Schmid-Grendelmeier P; Glatz M
Ther Umsch; 2016; 73(8):463-468. PubMed ID: 27731787
[No Abstract] [Full Text] [Related]
30. Common superficial fungal infections in patients with AIDS.
Aly R; Berger T
Clin Infect Dis; 1996 May; 22 Suppl 2():S128-32. PubMed ID: 8722840
[TBL] [Abstract][Full Text] [Related]
31. Tinea versicolor treated with terbinafine 1% solution.
Savin R; Eisen D; Fradin MS; Lebwohl M
Int J Dermatol; 1999 Nov; 38(11):863-5. PubMed ID: 10583623
[No Abstract] [Full Text] [Related]
32. The superficial mycoses.
Assaf RR; Weil ML
Dermatol Clin; 1996 Jan; 14(1):57-67. PubMed ID: 8821158
[TBL] [Abstract][Full Text] [Related]
33. The aetiology of dandruff and the mode of action of therapeutic agents.
Shuster S
Br J Dermatol; 1984 Aug; 111(2):235-42. PubMed ID: 6235835
[No Abstract] [Full Text] [Related]
34. Management of common superficial fungal infections in patients with AIDS.
Elmets CA
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S60-3. PubMed ID: 8077510
[TBL] [Abstract][Full Text] [Related]
35. Seborrheic dermatitis: a clinical practice snapshot.
Schmidt JA
Nurse Pract; 2011 Aug; 36(8):32-7. PubMed ID: 21768832
[TBL] [Abstract][Full Text] [Related]
36.
Sharma A; Rabha D; Ahmed G
Indian J Dermatol Venereol Leprol; 2017; 83(2):249-251. PubMed ID: 27852993
[No Abstract] [Full Text] [Related]
37. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa.
Nakano Y; Wada M; Tani H; Sasai K; Baba E
J Vet Med Sci; 2005 Dec; 67(12):1243-7. PubMed ID: 16397383
[TBL] [Abstract][Full Text] [Related]
38. [Pityrosporumfolliculitis (malasseziafolliculitis)].
Kortüm AK; Meller S; Hengge U; Kruse R; Reifenberger J; Bruch-Gerharz D
Hautarzt; 2006 Oct; 57(10):908-9. PubMed ID: 16960729
[No Abstract] [Full Text] [Related]
39. [Current possibilities of using antimyocotic drugs in the treatment of various skin disorders].
Choczaj-Kukuła A; Kwaśniewska J
Wiad Parazytol; 2004; 50(2):125-33. PubMed ID: 16859015
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species.
Uchida K; Nishiyama Y; Tanaka T; Yamaguchi H
Int J Antimicrob Agents; 2003 Mar; 21(3):234-8. PubMed ID: 12636984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
